Framework for equitable allocation of COVID-19 vaccine / Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, editors ; Committee on Equitable Allocation of Vaccine for the Novel Coronavirus, Board on Health Sciences Policy, Board on Population Health and Public Health Practice, Health and Medicine Division
In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time frame. Vaccination against this novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), offers the possibility of significantly reducing severe morbidity and mortality and transmission when deployed alongside other public health strategies and improved therapies. Health equity is intertwined with the impact of COVID-19 and there are certain populations that are at increased risk of severe illness or death from COVID-19. In the United States and worldwide, the pandemic is having a disproportionate impact on people who are already disadvantaged by virtue of their race and ethnicity, age, health status, residence, occupation, socioeconomic condition, or other contributing factors. Framework for Equitable Allocation of COVID-19 Vaccine offers an overarching framework for vaccine allocation to assist policy makers in the domestic and global health communities. Built on widely accepted foundational principles and recognizing the distinctive characteristics of COVID-19, this report's recommendations address the commitments needed to implement equitable allocation policies for COVID-19 vaccine..
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
[2020] |
---|---|
Erschienen: |
Washington, DC: The National Academies Press ; 2020 |
Reihe: |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gayle, Helene D. [HerausgeberIn] |
---|
Links: |
www.ncbi.nlm.nih.gov [teilw. kostenfrei] |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed March 3, 2021) |
---|
Umfang: |
1 online resource (1 PDF file (xix, 252 pages)) ; illustrations. |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
177318363X |
---|
LEADER | 01000cam a22002652 4500 | ||
---|---|---|---|
001 | 177318363X | ||
003 | DE-627 | ||
005 | 20230428011913.0 | ||
007 | cr uuu---uuuuu | ||
008 | 211011s2020 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)177318363X | ||
035 | |a (DE-599)KEP068719620 | ||
035 | |a (NCBI)9917747503406676 | ||
035 | |a (EBP)068719620 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
245 | 1 | 0 | |a Framework for equitable allocation of COVID-19 vaccine |c Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, editors ; Committee on Equitable Allocation of Vaccine for the Novel Coronavirus, Board on Health Sciences Policy, Board on Population Health and Public Health Practice, Health and Medicine Division |
264 | 1 | |a Washington, DC |b The National Academies Press |c [2020] | |
300 | |a 1 online resource (1 PDF file (xix, 252 pages)) |b illustrations. | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
490 | 0 | |a Consensus study report | |
500 | |a Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed March 3, 2021) | ||
520 | |a In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time frame. Vaccination against this novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), offers the possibility of significantly reducing severe morbidity and mortality and transmission when deployed alongside other public health strategies and improved therapies. Health equity is intertwined with the impact of COVID-19 and there are certain populations that are at increased risk of severe illness or death from COVID-19. In the United States and worldwide, the pandemic is having a disproportionate impact on people who are already disadvantaged by virtue of their race and ethnicity, age, health status, residence, occupation, socioeconomic condition, or other contributing factors. Framework for Equitable Allocation of COVID-19 Vaccine offers an overarching framework for vaccine allocation to assist policy makers in the domestic and global health communities. Built on widely accepted foundational principles and recognizing the distinctive characteristics of COVID-19, this report's recommendations address the commitments needed to implement equitable allocation policies for COVID-19 vaccine. | ||
650 | 2 | |a COVID-19 Vaccines |x supply & distribution |0 https://id.nlm.nih.gov/mesh/D000086663Q000600 | |
650 | 2 | |a COVID-19 |x prevention & control |0 https://id.nlm.nih.gov/mesh/D000086382Q000517 | |
650 | 2 | |a Pandemics |x prevention & control |0 https://id.nlm.nih.gov/mesh/D058873Q000517 | |
650 | 2 | |a Health Care Rationing |0 https://id.nlm.nih.gov/mesh/D015276 | |
650 | 2 | |a Resource Allocation |0 https://id.nlm.nih.gov/mesh/D040841 | |
650 | 2 | |a Health Equity |0 https://id.nlm.nih.gov/mesh/D000069576 | |
651 | 2 | |a United States |0 https://id.nlm.nih.gov/mesh/D014481 | |
700 | 1 | |a Gayle, Helene D. |e herausgeberin |4 edt | |
700 | 1 | |a Foege, William H. |d 1936- |e herausgeberin |4 edt | |
700 | 1 | |a Brown, Lisa |e herausgeberin |4 edt | |
700 | 1 | |a Kahn, Benjamin |e herausgeberin |4 edt | |
710 | 2 | |a National Academies of Sciences, Engineering, and Medicine (U.S.). |b Committee on Equitable Allocation of Vaccine for the Novel Coronavirus, |e MitwirkendeR |4 ctb | |
710 | 2 | |a National Academies of Sciences, Engineering, and Medicine (U.S.). |b Board on Population Health and Public Health Practice, |e MitwirkendeR |4 ctb | |
856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/books/NBK562672/ |m X:NCBI |x Verlag |z teilw. kostenfrei |
912 | |a ZDB-193-NCB | ||
912 | |a GBV_ILN_22 | ||
912 | |a ISIL_DE-18 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_22_i06404 | ||
912 | |a GBV_ILN_40 | ||
912 | |a ISIL_DE-7 | ||
912 | |a GBV_ILN_74 | ||
912 | |a ISIL_DE-354 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a ISIL_DE-25 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a ISIL_DE-180 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a ISIL_DE-15 | ||
951 | |a BO | ||
980 | |2 22 |1 01 |x 0018 |b 3994080746 |h h64 NCBI |y zi06404 |z 21-10-21 | ||
980 | |2 40 |1 01 |x 0007 |b 3994006996 |h OLR-NCB-BOOKSHELF |y xsn |z 21-10-21 | ||
980 | |2 74 |1 01 |x 0354 |b 3999783265 |c 09 |f E-Bibl |d EM 0000 |e --%%-- |j --%%-- |y ze |z 08-11-21 | ||
980 | |2 2003 |1 01 |x DE-25 |b 3995675069 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Open Access |y l01 |z 25-10-21 | ||
980 | |2 2009 |1 01 |x DE-180 |b 3987673192 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 11-10-21 | ||
980 | |2 2010 |1 01 |x DE-15 |b 3987761377 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Open Access |y l01 |z 11-10-21 | ||
981 | |2 22 |1 01 |x 0018 |r https://www.ncbi.nlm.nih.gov/books/NBK562672/ | ||
981 | |2 40 |1 01 |x 0007 |y Volltext, Open Access |r https://www.ncbi.nlm.nih.gov/books/NBK562672/ | ||
981 | |2 74 |1 01 |x 0354 |r https://www.ncbi.nlm.nih.gov/books/NBK562672/ | ||
981 | |2 2003 |1 01 |x DE-25 |r https://www.ncbi.nlm.nih.gov/books/NBK562672/ | ||
981 | |2 2010 |1 01 |x DE-15 |y Online-Zugriff |r https://www.ncbi.nlm.nih.gov/books/NBK562672/ | ||
985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
985 | |2 74 |1 01 |x 0354 |a EM 0000 | ||
995 | |2 22 |1 01 |x 0018 |a h64 NCBI | ||
995 | |2 22 |1 01 |x 0018 |a h64 freie Ressource | ||
995 | |2 40 |1 01 |x 0007 |a OLR-NCB-BOOKSHELF |